Aldeyra Therapeutics, Inc. Liquidation Value
ALDX
Other
Cash & Equivalents
$70.04M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $70.04M
Total Obligations: -$43.39M
$26.65M
Per share: $0.44
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $70.04M
AR: $0
Total Obligations: -$43.39M
$26.65M
Per share: $0.44
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $70.04M
AR: $0
Inventory: $0
Total Obligations: -$43.39M
$26.65M
Per share: $0.44
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $26.65M | $0.44 |
| Liquid Liquidation Value | $26.65M | $0.44 |
| Operating Liquidation Value | $26.65M | $0.44 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $70.04M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $27.81M |
| Long-term Debt | $15.30M |
| Op. Lease Liability | $280,537 |
| Finance Lease | N/A |
| Shares Outstanding | 60.2M |
Explore all 150 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $70.04M | N/A | N/A | $158,461 | $27.81M | $15.30M | $280,537 | N/A |
| 2025-09-30 | $59.34M | N/A | N/A | $13,423 | $28.48M | $15.30M | $344,484 | N/A |
| 2025-06-30 | $41.24M | N/A | N/A | $1.46M | $29.53M | $15.30M | $406,998 | N/A |
| 2025-03-31 | $50.35M | N/A | N/A | $346,146 | $14.29M | $15.10M | $468,111 | N/A |
▼ Community Notes